短期的l-氨酸治疗可以缓解糖尿病引起的皮肤原体早期损伤
Irena Miler1, Mihailo D Rabasovic2, Sonja Askrabic2
1Center for Biosystems, BioSense Institute, University of Novi Sad, Dr Zorana Djindjica 1, 21000 Novi Sad, Serbia.
Bioengineering (Basel, Switzerland)
|April 27, 2024
概括
糖尿病的皮肤并发症包括原体损伤. 在糖尿病老鼠中,L-氨酸治疗可以抵消早期的原蛋白变化,显示出预防和治疗皮肤损伤的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 皮肤病学 皮肤病学
- 生物物理学的生物物理.
背景情况:
- 糖尿病皮肤并发症与原蛋白的结构变化有关.
- 了解这些变化对于开发有效治疗方法至关重要.
研究的目的:
- 在早期糖尿病期间调查大鼠皮肤原I的结构变化.
- 评估l-阿尔金因治疗在缓解这些变化的有效性.
主要方法:
- 利用光子方法,包括拉曼光谱,作为光学诊断工具.
- 分析了原纤维结构和分子构造 (胺基I和II).
- 量化林和氧林水平,以评估原蛋白合成.
主要成果:
- 早期糖尿病诱导的异质原纤维损伤 ("不一致的模式").
- 拉曼光谱检测显示了分子水平 (胺基I和II) 上显著的原形状变化.
- 治疗L-氨酸部分逆转了形状变化和增加了氨酸/氧氨酸,表明原蛋白合成得到改善.
结论:
- 糖尿病导致早期的,分子水平的皮肤原体结构损伤.
- L-氨酸治疗在减弱和潜在地预防糖尿病原体损伤方面显示出前景.
- 光子方法是有效的诊断早期的原蛋白变化.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


